BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data

Published on 4 Dec 2023 on Zacks via Yahoo Finance

BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data

BiomX Inc. PHGE recently released favorable data from Part 2 of its Phase 1b/2a trial. This trial has assessed the efficacy of the novel phage cocktail, BX004, in treating chronic pulmonary infections caused by Pseudomonas aeruginosa (P. aeruginosa) in cystic fibrosis (CF) patients.

The study has been addressed as a 'watershed moment' by experts demonstrating the safety and tolerability of BX004 and its advanced clinical impact.

A Few Words on BX004

Read the rest of the article

NASDAQ.DXCM price evolution

NYSE.PHGE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

3 Stocks On US Exchange Estimated To Be Undervalued By Up To 36.2%

As the U.S. stock market continues to reach new heights, with the S&P 500 recently setting a reco...

Simply Wall St. · via Yahoo Finance 19 Feb 2025

Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts?

We recently compiled a list of the 12 Best Internet of Things Stocks To Buy According to Analysts...

Insider Monkey · via Yahoo Finance 18 Feb 2025

NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight

In 2025 and 2026, DXCM is expected to report earnings growth of 20.7% and 21.6%, respectively. Yo...

Zacks · via Yahoo Finance 18 Feb 2025

Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their...

DexCom, Inc. (NASDAQ:DXCM) last week reported its latest yearly results, which makes it a good ti...

Simply Wall St. · via Yahoo Finance 15 Feb 2025

DexCom Stock Rises Despite Q4 Earnings Miss & Lower Margins

DXCM's fourth-quarter 2024 earnings decline despite increasing sales. Its performance in 2025 is...

Zacks · via Yahoo Finance 14 Feb 2025

DexCom (DXCM) Q4 2024 Earnings Call Transcript

My name is Abby, and I will be your conference operator today. At this time, I would like to welc...

Motley Fool · via Yahoo Finance 13 Feb 2025

DXCM's Preliminary Results Show Strong Growth: How to Play the Stock?

DexCom stock shines with strong fourth quarter and full-year 2024 preliminary results, driven by...

Zacks · via Yahoo Finance 21 Jan 2025

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

As the United States stock market shows signs of optimism with futures indicating a positive open...

Simply Wall St. · via Yahoo Finance 21 Jan 2025

DexCom (NASDAQ:DXCM) shareholder returns have been decent, earning 44% in 5...

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd...

Simply Wall St. · via Yahoo Finance 18 Jan 2025

United States shares lower at close of trade; Dow Jones Industrial Average down...

United States shares lower at close of trade; Dow Jones Industrial Average down 0.16%

Investing.com 17 Jan 2025

News

BiomX (PHGE) Reports Positive Pulmonary Infection Treatment Data

NASDAQ.DXCM price evolution

NYSE.PHGE price evolution

Want to become a better investor?